LUND, Sweden, Nov. 30 2017 /PRNewswire/ -- NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF), the mitochondrial medicine company, today announced an increase of the number of shares and votes in NeuroVive of 1,760,000 as a result of a directed share issue in NeuroVive...
from PR Newswire: //www.prnewswire.co.uk/news-releases/amended-number-of-shares-and-votes-in-neurovive-pharmaceutical-ab-publ-660953523.html
No comments:
Post a Comment